These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24287290)

  • 21. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
    Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
    Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
    Forsea AM; Müller C; Riebeling C; Orfanos CE; Geilen CC
    Br J Cancer; 2004 Aug; 91(4):803-10. PubMed ID: 15280922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate treatment inhibits the growth of prostate cancer cells.
    Lee MV; Fong EM; Singer FR; Guenette RS
    Cancer Res; 2001 Mar; 61(6):2602-8. PubMed ID: 11289137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
    Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
    Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.
    Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
    Pathol Oncol Res; 2018 Jul; 24(3):557-565. PubMed ID: 28744693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of pamidronate in breast cancer cells transformed by low doses of α-particles and estrogen in vitro.
    Ponce-Cusi R; Calaf GM
    Int J Oncol; 2015; 46(6):2663-9. PubMed ID: 25873070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
    Wada A; Fukui K; Sawai Y; Imanaka K; Kiso S; Tamura S; Shimomura I; Hayashi N
    J Hepatol; 2006 Jan; 44(1):142-50. PubMed ID: 16298452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
    Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment.
    Derenne S; Amiot M; Barillé S; Collette M; Robillard N; Berthaud P; Harousseau JL; Bataille R
    J Bone Miner Res; 1999 Dec; 14(12):2048-56. PubMed ID: 10620064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
    Koshimune R; Aoe M; Toyooka S; Hara F; Ouchida M; Tokumo M; Sano Y; Date H; Shimizu N
    BMC Cancer; 2007 Jan; 7():8. PubMed ID: 17222343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of proliferation and invasive behavior of human metastatic breast cancer cells by dietary supplement BreastDefend.
    Jiang J; Wojnowski R; Jedinak A; Sliva D
    Integr Cancer Ther; 2011 Jun; 10(2):192-200. PubMed ID: 20926736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival.
    Minegaki T; Fukushima S; Morioka C; Takanashi H; Uno J; Tsuji S; Yamamoto S; Watanabe A; Tsujimoto M; Nishiguchi K
    Dis Esophagus; 2016 Aug; 29(6):656-62. PubMed ID: 25894100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.
    Aparicio A; Gardner A; Tu Y; Savage A; Berenson J; Lichtenstein A
    Leukemia; 1998 Feb; 12(2):220-9. PubMed ID: 9519785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo.
    Issat T; Nowis D; Legat M; Makowski M; Klejman MP; Urbanski J; Skierski J; Koronkiewicz M; Stoklosa T; Brzezinska A; Bil J; Gietka J; Jakóbisiak M; Golab J
    Int J Oncol; 2007 Jun; 30(6):1413-25. PubMed ID: 17487362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
    Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S
    Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.
    Reinholz GG; Getz B; Sanders ES; Karpeisky MY; Padyukova NSh; Mikhailov SN; Ingle JN; Spelsberg TC
    Breast Cancer Res Treat; 2002 Feb; 71(3):257-68. PubMed ID: 12002344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.
    Iguchi K; Tatsuda Y; Usui S; Hirano K
    Eur J Pharmacol; 2010 Sep; 641(1):35-40. PubMed ID: 20519142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.